Ifp Advisors, Inc Alector, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$21.65 - $39.49 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$15.5 - $22.48 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$14.84 - $22.23 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$9.4 - $16.7 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$10.54 - $24.96 $0 - $0	0 New
Q2 2020 Aug 05, 2020	BUY	$21.87 - $33.11 $0 - $0	0 New

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.